Follica
Follica announced today the completion of a female pilot study utilizing its proprietary microneedling device along with topical drug application. Female Hair Growth Study On December 8, 2020, a peer-reviewed study sponsored by Follica and titled “A Pilot Evaluation of Scalp Skin Wounding to Promote Hair Growth in Female Pattern Hair Loss” was published in…
Read MoreWe have yet another company moving towards a pivotal trial for hair regrowth in 2020. On June 4, 2020, Follica issued a press release to announce a positive ‘end of phase 2 meeting’ with the US FDA in preparation to begin a phase 3 trial this year. The release also outlines details of Follica’s phase…
Read MoreUpdated 12/19/19 Today, I received an email from Follica management which shared the company’s latest press release. The company has just announced positive topline data from its FOL-004 safety and efficacy optimization study which was carried out in 2019. According to the release, the study was designed to determine the optimal treatment regimen involving Follica’s…
Read MoreBoston based hair growth company Follica has announced positive data from its ongoing safety and optimization study and is prepared to move into a pivotal FDA study later this year. Upon checking my email this morning I found a message from a top level executive at Follica pointing me to a press release sent out…
Read MorePuretech Health, the parent company of Follica, has recently issued a 2018 Annual Report to shareholders which contains news about its long-standing hair growth company. New Proprietary Compounds Among the important Follica news shared in the Puretech Annual Report is the mentioning of “next-generation proprietary compounds.” Yes, that compounds with an “s”, as in more…
Read MoreI’ve got a good feeling about 2017… For the past several years we have been pacified by the news of a research study or startup company working on a treatment that grows hair. Ultimately, we would prefer the treatment in our hands, but reading about it on a computer screen has been supportive as well.…
Read MoreThe times they are a-changing. Nowadays you can’t even take a trip to the fridge to grab more hummus dip without some hair growth startup rolling out their new website and business plan. Jokes aside, Follica has been the ultimate tight-lipped company in the hair regeneration biz for about 8 years now. To be honest,…
Read MoreHey there everybody, nice to see you all again. In this edition of Weekly Thoughts we find a new company with some ambiguous, yet noteworthy, claims about their hair growth technology, an update on Follica’s new pivot, and some background information on Samumed’s founder and CEO. Thorn Medical Makes Big Claim Last week, a press…
Read MoreI hope it’s been a good week, everybody. I’m still planning on releasing some exclusive posts soon, one being from a top researcher in the hair science world. Hopefully, sometime next week I will have an article ready to go. In the meantime, I have two noteworthy items to share in this weeks, Weekly Thoughts.…
Read MoreFollica made a big splash in the hair regeneration world when it was first announced about 8 years ago. The approach was new and was based on manipulating the wound healing process of skin to induce hair follicle generation. Dr. George Cotsarelis quickly became the recognized face of the company. Since then, Follica has been…
Read More